|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Role of osteoprotegerin(OPG) in cancer显示文摘 | Holen I Shipman CM | 2006 | Clin Sd (Lond)2006，110，3： | 1 |
| 2 | Role of osteoprotegerin(OPG) in cancer显示文摘 | Shipman CM | 2006 | Clin Sci(Lond)2006，110，3： | 1 |
| 3 | Osteoprotegerin is a soluble decoy reeeptor for tumor necrosis factor related apop- tosis inducing ligand/Ap02 ligand and can function as a paraerine survival factor for human myeloma cells显示文摘 | Shipman CM Croueher PI | 2003 | Cancer Res2003，63，5： | 1 |
| 4 | 显示文摘 | Croucher PI Shipman CM Lippitt J | 2001 | Blood2001，98，： | 1 |
| 5 | Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease显示文摘 | Croucher PI Shipman CM Camp BV | 2003 | Cancer2003，97，3： | 1 |
| 6 | Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease显示文摘 | Croucher PI Shipman CM Van Camp B | 2003 | Cancer2003，97，3： | 1 |
| 7 | Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma显示文摘 | Croucher PI Shipman CM Lippitt J | 2001 | Blood2001，98，13： | 1 |
| 8 | The Bisphosphonate,zoledronic acid,induces apoptosis 9f brest cancer cells:evidence for synergy with pacliataxel显示文摘 | Jagdev SP Coleman RE Shipman CM | 2001 | Br J Cancer2001，84，： | 1 |
| 9 | Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma显示文摘 | Croucher P1 Shipman CM Lippitt J | 2001 | Blood2001，98，13： | 1 |
| 10 | The bisphosphonate,zoledronic acid,induces apoptosis of breast cancer cells:evidence for synergy with paclitaxel显示文摘 | Jadgev SP Coleman RE Shipman CM | 2001 | J Cancer(Br)2001，84，： | 1 |
| 11 | Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells显示文摘 | Croucher PI | 2003 | Cancer Res2003，63，： | 1 |
| 12 | The bisphosphonate,zoledronic acid,induces apoptosis of breast cancer cells:evidence for synergy with paclitaxel显示文摘 | Jagdev SP Coleman RE Shipman CM | 2001 | Br J Cancer2001，84，8： | 1 |
| 13 | The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel显示文摘 | Jagdev SP Coleman RE Shipman CM | 2001 | Br J Cancer2001，84，： | 1 |
| 14 | The bisphosphonate,zoledronic acid,induces apoptosis of breast cancer cells:evidence for synergy with paclitaxel显示文摘 | Jagdev SP Coleman RE Shipman CM | 2001 | Br J Cancer2001，84，： | 1 |
| 15 | The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel 显示文摘 | Jagdev SP Coleman RE Shipman CM | 2001 | Sr J Cancer2001，84，8： | 1 |
| 16 | The bisphosphonate,zoledronic acid,induces apoptosis of breast cancer cells:evidence for synergy with paclitaxel显示文摘 | Jagdev SP Coleman RE Shipman CM | 2001 | Br J Cancer2001，84，： | 1 |
| 17 | Bisphosphonates-mechanisms of action in multiple myeloma 显示文摘 | Shipman CM Rogers MJ Vanderkerken K | 2000 | Acta Oncol2000，39，7： | 1 |
| 18 | Role of osteoprotegerin (OPG) in cancer 显示文摘 | Holen I Shipman CM | 2006 | Clin Sci(Lond)2006，110，3： | 1 |
| 19 | The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer ceils: evidence for synergy with paclitaxel 显示文摘 | Jagdev SP Coleman RE Shipman CM | 2001 | Br J Cancer2001，84，8： | 1 |
| 20 | Bisphonates-mechanisms of action in multiple myeloma显示文摘 | | 2000 | Acta Oncol2000，39，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员